Поиск по каталогу |
(строгое соответствие)
|
- Профессиональная
- Научно-популярная
- Художественная
- Публицистика
- Детская
- Искусство
- Хобби, семья, дом
- Спорт
- Путеводители
- Блокноты, тетради, открытки
The relationship between Osteoporosis and COVID 19.
В наличии
Местонахождение: Алматы | Состояние экземпляра: новый |
Бумажная
версия
версия
Автор: Ala'a Al-khalaf,Firas Al-Rahawanji and Merna Abo Moughdab
ISBN: 9786203860580
Год издания: 1905
Формат книги: 60×90/16 (145×215 мм)
Количество страниц: 72
Издательство: LAP LAMBERT Academic Publishing
Цена: 23635 тг
Положить в корзину
Способы доставки в город Алматы * комплектация (срок до отгрузки) не более 2 рабочих дней |
Самовывоз из города Алматы (пункты самовывоза партнёра CDEK) |
Курьерская доставка CDEK из города Москва |
Доставка Почтой России из города Москва |
Аннотация: Osteoporosis is a major concern all over the world. Therefore, the major aim of our study is to focus on this popular disease and its correlation with aging, a gradual loss of bone mass and results in osteopenia and osteoporosis. Heritable factors account for 60–80% of optimal bone mineralization. Modifiable factors, such as weight-bearing exercise, nutrition, body mass, and hormonal milieu, play an important role in the development of osteopenia and osteoporosis in adulthood. Currently, anti-osteoporosis agents, including estrogen, bisphosphonates, and selective estrogen receptor modulators (SERMs), are the drugs of choice for osteoporosis. Other treatments include parathyroid hormone (PTH) as well as the nutritional support of calcium and vitamin D. Taking into consideration that Osteoporosis is a silent disease we will introduce a new device for early detection which are used worldwide and to follow up therapy. Finally, we will highlight a new link in between one therapy of this disease which could be a potential treatment for Corona epidemic crises.
Ключевые слова: Osteoporosis, osteopenia, anti-osteoporosis agents, estrogen, Bisphosphonates, selective estrogen receptor modulators, SERMs, parathyroid hormone, Nutritional Support, postmenopausal